| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005025299 |
| P356 | DOI | 10.1186/S12967-015-0540-Y |
| P932 | PMC publication ID | 4501123 |
| P698 | PubMed publication ID | 26169624 |
| P5875 | ResearchGate publication ID | 280058735 |
| P2093 | author name string | Peng Xie | |
| Zhao Liu | |||
| Yi Xu | |||
| Ting Huang | |||
| Peng Zheng | |||
| Zheng Fang | |||
| Peng-Fei Cheng | |||
| Li-Bo Zhao | |||
| Xiao-Tong Zhang | |||
| Shun-Jie Bai | |||
| Mei-Ling Liu | |||
| Wei-Hua Shao | |||
| Xiang-Yu Du | |||
| Xue-Jiao Xu | |||
| Zhi-Guo Qi | |||
| P2860 | cites work | Activation of the cholinergic anti-inflammatory system in peripheral blood mononuclear cells from patients with borderline personality disorder. | Q44269991 |
| Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication | Q44401758 | ||
| Blood mononuclear cell gene expression signature of postpartum depression | Q44594243 | ||
| Morphine withdrawal produces circadian rhythm alterations of clock genes in mesolimbic brain areas and peripheral blood mononuclear cells in rats | Q46042359 | ||
| Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia | Q46055055 | ||
| Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder | Q46767416 | ||
| Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla | Q46960149 | ||
| Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration | Q48094042 | ||
| Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia. | Q48830689 | ||
| Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders. | Q48938985 | ||
| Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocyt | Q50309754 | ||
| 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. | Q50663896 | ||
| Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. | Q51495641 | ||
| Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. | Q51850457 | ||
| Burden of care and general health in families of patients with schizophrenia. | Q51924848 | ||
| Age- and dose-dependent glucose-induced increases in memory and attention in schizophrenia. | Q52029747 | ||
| Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. | Q54280525 | ||
| The use of the area under the ROC curve in the evaluation of machine learning algorithms | Q56594447 | ||
| Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients | Q60649880 | ||
| A systematic review of the prevalence of schizophrenia | Q21144720 | ||
| Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation | Q21260256 | ||
| Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia | Q28469040 | ||
| Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients | Q30468799 | ||
| Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. | Q33241006 | ||
| The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples | Q33332023 | ||
| Size of burden of schizophrenia and psychotic disorders | Q33341221 | ||
| Parallel changes in gene expression in peripheral blood mononuclear cells and the brain after maternal separation in the mouse | Q33506763 | ||
| Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium | Q33902752 | ||
| Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients | Q34185951 | ||
| Oxidative stress in schizophrenia: an integrated approach | Q34494844 | ||
| Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. | Q34911118 | ||
| Analysis of whole genome biomarker expression in blood and brain | Q34994239 | ||
| Changes in BMI, duration of overweight and obesity, and glucose metabolism: 45 years of follow-up of a birth cohort | Q35179968 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Metabolomics tools for identifying biomarkers for neuropsychiatric diseases | Q37419784 | ||
| Revisiting the diagnosis of schizophrenia: where have we been and where are we going? | Q37825634 | ||
| Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia | Q43062918 | ||
| The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls | Q44091620 | ||
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 226 | |
| P577 | publication date | 2015-07-14 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study | |
| P478 | volume | 13 |
| Q64283871 | Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder |
| Q58599983 | Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments |
| Q89507956 | Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study |
| Q26752342 | Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity |
| Q59335564 | Is It Possible to Predict the Future in First-Episode Psychosis? |
| Q47642189 | Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers |
| Q36743314 | Metabolomic Profiling of Post-Mortem Brain Reveals Changes in Amino Acid and Glucose Metabolism in Mental Illness Compared with Controls |
| Q92193020 | Metabolomics and Biomarker Discovery |
| Q57183034 | Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells |
| Q49627122 | Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells. |
| Q104135053 | Plasma amino acids profile in first-episode psychosis, unaffected siblings and community-based controls |
| Q92292838 | Systemic Immuno-metabolic alterations in chronic obstructive pulmonary disease (COPD) |
Search more.